High Tech Pharm Co. Ltd (106190) — Capital Reinvestment Ratio

Latest as of September 2025: 0.08x

High Tech Pharm Co. Ltd (106190) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩6.60 Billion) in capital expenditures (₩516.00 Million). Check tangible equity quality of High Tech Pharm Co. Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

₩6.60 Billion
KRW

Capital Expenditures

₩516.00 Million
KRW

Data as of

Sep 2025
Most recent filing

High Tech Pharm Co. Ltd Capital Reinvestment Ratio (2014–2024)

This chart tracks High Tech Pharm Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 106190 cash flow metrics.

Annual Capital Reinvestment Ratio for High Tech Pharm Co. Ltd (2014–2024)

Year-by-year Capital Reinvestment Ratio for High Tech Pharm Co. Ltd from 2014 to 2024. See High Tech Pharm Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.15x ₩14.69 Billion ₩2.13 Billion ▼ -91.7%
2023 1.75x ₩2.91 Billion ₩5.09 Billion ▲ +1310.7%
2021 0.12x ₩6.93 Billion ₩859.60 Million ▼ -85.7%
2019 0.87x ₩2.48 Billion ₩2.16 Billion ▼ -47.9%
2018 1.67x ₩5.38 Billion ₩8.96 Billion ▼ -19.4%
2017 2.07x ₩5.45 Billion ₩11.27 Billion ▼ -87.2%
2016 16.13x ₩1.45 Billion ₩23.35 Billion ▲ +950.2%
2015 1.54x ₩12.71 Billion ₩19.52 Billion ▲ +66.5%
2014 0.92x ₩10.17 Billion ₩9.38 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow